Clinical trials
Not yet recruiting Phase 2 Brain Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 4 |
| 2025 | 2 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 1 |
| Convalife (Shanghai) Co., Ltd. | 1 |
| Costas Hadjipanayis | 1 |
| Guangzhou Medical University | 1 |
| Li-kun Chen | 1 |
| Nanfang Hospital, Southern Medical University | 1 |
| National Taiwan University Hospital | 1 |
| Nationwide Children's Hospital | 1 |
| Taizhou Hospital | 1 |
| Tianjin Medical University Cancer Institute and Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brain Neoplasms | 13 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Breast Neoplasms | 2 |
| Glioma | 2 |
| Adenocarcinoma of Lung | 1 |
| Diffuse Intrinsic Pontine Glioma | 1 |
| Ependymoma | 1 |
| Lung Neoplasms | 1 |
| Triple Negative Breast Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.